Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

Cited by (901)

Items 301–400 of 901

1. The Year in Atherothrombosis
   Javier Sanz, Pedro Moreno, Valentı́n Fuster · 2013 · Journal of the American College of Cardiology
2. Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
   Ciaran Navin Kohli-Lynch, James Lewsey, Kathleen A. Boyd, Dustin D. French, Neil Jordan, Andrew E. Moran, Naveed A. Sattar, David Preiss, Andrew H. Briggs · 2022 · Circulation
3. Reprint of: Impact of Lipids on Cardiovascular Health
   Brian A. Ference, Ian M Graham, Lale S Tokgözoğlu, Alberico Luigi Catapano · 2018 · Journal of the American College of Cardiology
4. Can atherosclerosis be cured?
   John T. Wilkins, Samuel S. Gidding, Jennifer G. Robinson · 2019 · Current Opinion in Lipidology
5. Low Doses of Eicosapentaenoic Acid and Docosahexaenoic Acid From Fish Oil Dose-Dependently Decrease Serum Triglyceride Concentrations in the Presence of Plant Sterols in Hypercholesterolemic Men and Women
   Rouyanne T. Ras, Isabelle Demonty, Yvonne E. M. P. Zebregs, Johan F.A. Quadt, Johan Olsson, Elke A. Trautwein · 2014 · Journal of Nutrition
6. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies
   RICHARD J. KONES, Umme Rumana · 2015 · Drugs
7. A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor
   Antoine Rimbert, Nawar Dalila, Justina Clarinda Wolters, Nicolette Huijkman, Marieke Smit, Niels Kloosterhuis, Marijn Riemsma, Ydwine T. van der Veen, Amika Singla, Freerk van Dijk et al. · 2019 · European Heart Journal
8. Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
   Dipali Kale, Amol Fatangare, Prasad B. Phapale, Albert Sickmann · 2023 · Cells
9. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality
   Guoyi Yang, Amy M. Mason, Angela Wood, Catherine Mary Schooling, Stephen Burgess · 2024 · JAMA Network Open
10. Approaches for strengthening causal inference regarding prenatal risk factors for childhood behavioural and psychiatric disorders
    Sarah Jane Lewis, Caroline L. Relton, Stanley Zammit, George Davey Smith · 2013 · Journal of Child Psychology and Psychiatry
11. Parent–child genetic testing for familial hypercholesterolaemia in an Australian context
    Jing Pang, Andrew C. Martin, Timothy R. Bates, Amanda J. Hooper, Damon A. Bell, John R. Burnett, Richard Norman, Gerald Francis Watts · 2018 · Journal of Paediatrics and Child Health
12. Prediction and management of CAD risk based on genetic stratification
    Robert Roberts, Arlene Campillo, Marin E. Schmitt · 2019 · Trends in Cardiovascular Medicine
13. Causal Inference Methods to Integrate Omics and Complex Traits
    Eleonora Porcu, Jennifer Sjaarda, Kaido Lepik, Cristian Carmeli, Liza Darrous, Jonathan Sulc, Ninon Mounier, Zoltán Kutalik · 2020 · Cold Spring Harbor Perspectives in Medicine
14. Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?
    Lecis, Dalgisio, Prandi, Francesca Romana, Barone, Lucy, Belli, Martina, Sergi, Domenico, Longo, Susanna, Muscoli, Saverio, Romeo, Francesco, Federici, Massimo, Lerakis, Stamatios et al. · 2023 · Biomolecules
15. Polygenic familial hypercholesterolaemia: does it matter?
    Evan A. Stein, Frederick Johan Raal · 2013 · The Lancet
16. Plant-based diets for children as a means of improving adult cardiometabolic health
    Małgorzata Agnieszka Desmond, Jakub G. Sobiecki, Mary S. Fewtrell, Jonathan C. K. Wells · 2018 · Nutrition Reviews
17. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL
    Chuang Li, Qiwen Chen, Mei Zhang, Yin Liu, Yushun Chu, Fanpeng Meng, Jianyu Wang, Jie Ting Tang, Jian Luo, Xiulong Niu et al. · 2021 · BMC Cardiovascular Disorders
18. Systematic comparison of Mendelian randomisation studies and randomised controlled trials using electronic databases
    Maria Sobczyk, Jie Zheng, George Davey Smith, Tom R. Gaunt · 2023 · BMJ Open
19. The Case for Treating Hypercholesterolemia at an Earlier Age
    Daniel Howard Steinberg, Scott M. Grundy · 2012 · Journal of the American College of Cardiology
20. New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk
    Gerald Klose, Frank Ulrich Beil, Hans Dieplinger, Arnold von Eckardstein, Bernhard Föger, Ioanna Gouni‐Berthold, Franz Heigl, Wolfgang Köenig, Gert M. Kostner, Ulf Landmesser et al. · 2014 · Wiener klinische Wochenschrift
21. Cardiovascular Disease Prevention: The Earlier the Better? A Review of Plant Sterol Metabolism and Implications of Childhood Supplementation
    Bianca Scolaro, Leticia F.S. de Andrade, Inar Alves de Castro · 2019 · International Journal of Molecular Sciences
22. Expressing Results From a Mendelian Randomization Analysis
    Stephen Burgess, Christopher J. O’Donnell, Dipender Gill · 2020 · JAMA Cardiology
23. Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study
    Liang He, Irina V. Culminskaya, Yury Loika, Konstantin G. Arbeev, Olivia Bagley, Matt Duan, Anatoliy I. Yashin, Alexander M. Kulminski · 2017 · Experimental Gerontology
24. Beyond statins: what to expect from add-on lipid regulating therapy?
    Ulrich Laufs, William Weintraub, Chris J. Packard · 2013 · European Heart Journal
25. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products
    Michael J. Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke, Rolf Weitkunat · 2018 · Biomarkers
26. Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy
    Chayakrit Krittanawong, Muzamil Khawaja, Robert S. Rosenson, Christopher Ian Amos, Vijay Nambi, Carl J. Lavie, Salim S. Virani · 2021 · Current Problems in Cardiology
27. Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials
    Parisa Rahmani, Ebru Melekoğlu, Sogand Tavakoli, Nasser Malekpour Alamdari, Pejman Rohani, Mohammad Hassan Sohouli · 2022 · Expert Review of Clinical Pharmacology
28. Beyond the Single SNP: Emerging Developments in Mendelian Randomization in the “Omics” Era
    Marie‐Jo Brion, Beben Benyamin, Peter M. Visscher, George Davey Smith · 2014 · Current Epidemiology Reports
29. Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology
    Carlos Escobar, Manuel P. Anguita, Vicente Arrarte, Vivencio Barrios, Angel R. Cequier, Juan Cosı́n-Sales, Isabel Egocheaga, Esteban López de Sá, L. Masana, Vicente Pallarés‐Carratalá et al. · 2019 · Revista Española de Cardiología (English Edition)
30. A phenome-wide association study of genetically mimicked statins
    Shun Li, Catherine Mary Schooling · 2021 · BMC Medicine
31. Adiponectin and the risk of gastrointestinal cancers in East Asians: Mendelian randomization analysis
    Hua Jiang, Daojun Hu, Jun Wang, Bo Zhang, Chiyi He, Jiyu Ning · 2022 · Cancer Medicine
32. Effects of blood lipids and lipid‐modifying drugs on intracranial aneurysms
    Baorui Zhang, Siyuan Dong, Yan Miao, Guangrong Song, Fei Yuan, Lang Liu, Saide Xia, Yongkai Qin, Xiaochuan Huo, Zhongxue Wu et al. · 2022 · European Journal of Neurology
33. Alternative lipid lowering strategies: State-of-the-art review of red yeast rice
    Lorenzo Buzzelli, Andrea Segreti, Daniela Di Gioia, Erika Lemme, Maria Rosaria Squeo, Antonio Nenna, Giuseppe Di Gioia · 2023 · Fitoterapia
34. Common genetic risk factors for coronary artery disease: new opportunities for prevention?
    Viktor Hamrefors · 2015 · Clinical Physiology and Functional Imaging
35. New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
    Ian M Graham, C.L. Shear, Pieter de Graeff, Caroline Boulton, Alberico Luigi Catapano, Wendy Gattis Stough, Stefan C Carlsson, Guy De Backer, Joseph Emmerich, Scott A. Greenfeder et al. · 2017 · European Heart Journal - Cardiovascular Pharmacotherapy
36. The Causal-Benefit Model to Prevent Cardiovascular Events
    Ciaran Navin Kohli-Lynch, George Thanassoulis, Michael J. Pencina, Daniel Sehayek, Karol Mateusz Pencina, Andrew Edward Moran, Allan D. Sniderman · 2024 · JACC Advances
37. MR-link-2: pleiotropy robust cis Mendelian randomization validated in three independent reference datasets of causality
    Adriaan van der Graaf, Robert Warmerdam, Chiara Auwerx, Toni Boltz, Dorret Irene Boomsma, Andrew Brown, Evans K. Cheruiyot, Emma E. Davenport, Théo Dupuis, Tõnu Esko et al. · 2025 · Nature Communications
38. A comparative study of four independent methods to measure LDL particle concentration
    Paul Nathan Hopkins, James V. Pottala, M. Nazeem Nanjee · 2015 · Atherosclerosis
39. LDL-Cholesterol: Standards of Treatment 2016: A German Perspective
    Winfried März, Hubert Scharnagl, Ioanna Gouni‐Berthold, Günther Silbernagel, Alexander Dressel, Tanja B. Grammer, Ulf Landmesser, Hans Dieplinger, Eberhard Windler, Ulrich Laufs · 2016 · American Journal of Cardiovascular Drugs
40. Low-Density Lipoprotein Cholesterol Treatment in the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Era
    Marc Steven Sabatine, Robert Patrick Giugliano · 2017 · JAMA Cardiology
41. miR‐23b‐3p and miR‐125b‐5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells
    Junfa Zeng, Zhaolin Zeng, Kai Zhang, Yue Zhao, Ya‐mi Liu, Jiaojiao Chen, Tong Hai, Dangheng Wei, Zhisheng Jiang, Zuo Wang · 2017 · Cell Biology International
42. LDL cholesterol: How low to go?
    Chris J. Packard · 2017 · Trends in Cardiovascular Medicine
43. New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease
    Julius L. Katzmann, Ulrich Laufs · 2019 · Current Cardiology Reports
44. Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations
    Yu‐Jin Kwon, Hyangkyu Lee, Su Jung Baik, Hyuk‐Jae Chang, Ji‐Won Lee · 2022 · Frontiers in Cardiovascular Medicine
45. Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus
    Yun Gi Kim, Joo Hee Jeong, Kyungdo Han, Seung‐Young Roh, Kyongjin Min, Hyoungsuk Lee, Yun Young Choi, Jaemin Shim, Jong‐Il Choi, Young‐Hoon Kim · 2023 · Cardiovascular Diabetology
46. The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes
    Tobias Andersson, Jonatan Nåtman, Georgios Mourtzinis, Johan‐Emil Bager, Kristina Bengtsson Boström, Stefan Franzén, Per Hjerpe · 2023 · European Journal of Preventive Cardiology
47. Will Obesity Increase the Proportion of Children and Adolescents Recommended for a Statin?
    Brian W. McCrindle, Pascal N. Tyrrell, Rae-Ellen Webb Kavey · 2013 · Circulation
48. Evolution and Outcomes of Premature Coronary Artery Disease
    Cara Lea Smith, Matthew E. Seigerman, Srinath Adusumalli, Jay S. Giri, Paul Nicolas Fiorilli, Daniel M. Kolansky, Taisei Kobayashi · 2021 · Current Cardiology Reports
49. Treatment of dyslipidemia
    Andrew Maxwell Tonkin, Allison Byrnes · 2014 · F1000Prime Reports
50. Lipid Screening in Children and Adolescents
    Elaine M. Urbina, Sarah D. de Ferranti · 2016 · JAMA
51. What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    Brian W. McCrindle, Samuel S. Gidding · 2016 · New England Journal of Medicine
52. HDL-cholesterol, genetics, and coronary artery disease: the myth of the ‘good cholesterol’?
    Ulf Landmesser, Stanley L. Hazen · 2018 · European Heart Journal
53. Is interleukin-6 the link between low LDL cholesterol and increased non-cardiovascular mortality in the elderly?
    James J. DiNicolantonio, Mark Frederick McCarty · 2018 · Open Heart
54. Recent advances in the management and implementation of care for familial hypercholesterolaemia
    Nick S.R. Lan, Archna Bajaj, Gerald Francis Watts, Marina Cuchel · 2023 · Pharmacological Research
55. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice
    Éric Bruckert, Jean Ferrières · 2014 · Archives of cardiovascular diseases
56. Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study
    Joel Nuotio, Mervi Oikonen, Costan G. Magnussen, Jorma S.A. Viikari, Nina Hutri‐Kähönen, Antti Jula, Russell J. Thomson, Matthew A. Sabin, Stephen R. Daniels, Olli Tuomas Raitakari et al. · 2015 · Atherosclerosis
57. An Evidence-Based Guide to Cholesterol-Lowering Guidelines
    David D. Waters, S. Matthijs Boekholdt · 2016 · Canadian Journal of Cardiology
58. LDL-Cholesterin und kardiovaskuläre Ereignisse: je niedriger desto besser?
    Raimund Weitgasser, Michaela Ratzinger, Margit Hemetsberger, Peter Siostrzonek · 2016 · Wiener Medizinische Wochenschrift
59. A phase 1 study to evaluate the safety and LDL cholesterol–lowering effects of RG7652 , a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9
    Amos Baruch, Diana Luca, Robert S. Kahn, Kyra J. Cowan, Maya K. Leabman, Nageshwar R. Budha, Cecilia Chiu, Yan Wu, Daniel Kirchhofer, Andrew S. Peterson et al. · 2017 · Clinical Cardiology
60. Using Mendelian randomization to understand and develop treatments for neurodegenerative disease
    Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi, Nicholas William Wood · 2020 · Brain Communications
61. Practical strategies for modulating foam cell formation and behavior
    Elisabeth Uitz · 2014 · World Journal of Clinical Cases
62. PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
    Bertrand Cariou, Zufeng Ding, Jawahar L. Mehta · 2016 · Atherosclerosis
63. Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women
    Julie A E van Oortmerssen, Janneke W.C.M. Mulder, Marte F. van der Bijl, Ruben J M Mijnster, Maryam Kavousi, Jeanine E. Roeters van Lennep · 2025 · Current Atherosclerosis Reports
64. Comprehensive genotyping in dyslipidemia: mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants
    Hayato Tada, Masa‐aki Kawashiri, Masakazu Yamagishi · 2017 · Journal of Human Genetics
65. Dyslipidemia in childhood and adolescence: from screening to management
    Elizabeth Yeung, Stephen R. Daniels, Sonali S. Patel · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
66. Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib
    Giovanni Caocci, Olga Mulas, Isabella Capodanno, Massimiliano Bonifacio, Mario Annunziata, Sara Galimberti, Luigiana Luciano, Mario Tiribelli, Bruno Martino, Fausto Castagnetti et al. · 2021 · Annals of Hematology
67. Is it Time for Single-Pill Combinations in Dyslipidemia?
    François Schiele, Leopoldo Pérez de Isla, Marcello Arca, Charalambos V. Vlachopoulos · 2021 · American Journal of Cardiovascular Drugs
68. Common single nucleotide polymorphisms at the NPC1L1 gene locus significantly predict cardiovascular risk in coronary patients
    Axel Muendlein, Andreas Leiherer, Christoph H. Saely, Philipp Rein, Daniela Zanolin, Elena Kinz, Eva‐Maria Brandtner, Peter Fraunberger, Heinz Drexel · 2015 · Atherosclerosis
69. Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
    Chunyue Guo, Han Cao, Guangliang Shan, Wei Zhao, Han Zhang, Kaijun Niu, Ze Qin Cui, Naijun Tang, Kuo Liu, Li Pan et al. · 2021 · Annals of Translational Medicine
70. ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia
    Kasliwal, Ravi R., Bansal, Manish, Gupta, Rajeev, Shah, Siddharth, Dani, Sameer, Oomman, Abraham, Pai, Vikas, Prasad, Guru Mallapa, Singhvi, Sunil, Patel, Jitendra et al. · 2016 · Nutrition
71. Effects of Cocoa Consumption on Cardiometabolic Risk Markers: Meta-Analysis of Randomized Controlled Trials
    Tainah O. P. Arisi, Diego Silveira da Silva, Elana Stein, Camila Weschenfelder, Patrícia Caetano de Oliveira, Aline Marcadenti, Alexandre Machado Lehnen, Gustavo Waclawovsky · 2024 · Nutrients
72. Statin therapy in primary and secondary cardiovascular disease prevention
    Rodis D. Paparodis, Dimitra Bantouna, Sarantis Livadas, Nicholas Angelopoulos · 2024 · Current Atherosclerosis Reports
73. Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis
    Dinesh Kumar Kalra, Kausik Kumar Ray, Archna Bajaj, Pamela R. Kushner, Meredith Leigh Wilcox, Mary R. Dicklin, Carol F. Kirkpatrick, Kevin Carl Maki · 2026 · Journal of clinical lipidology
74. Long-Lasting Control of LDL Cholesterol Induces a 40% Reduction in the Incidence of Cardiovascular Events: New Insights from a 7-Year Study
    Valentina Trimarco, Raffaele Izzo, Paola Gallo, Maria Virginia Manzi, Imma Forzano, Daniela Pacella, Gaetano Santulli, Bruno Trimarco · 2023 · Journal of Pharmacology and Experimental Therapeutics
75. The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study
    Arrigo F.G. Cicero, Federica Fogacci, Marina Giovannini, Elisabetta Rizzoli, Elisa Grandi, Sergio D’Addato, Claudio Borghi · 2023 · Nutrients
76. Implementation of the NHLBI Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Rationale and study design for Young Hearts, Strong Starts, a cluster-randomized trial targeting body mass index, blood pressure, and tobacco
    Kenneth A. LaBresh, Suzanne Lazorick, Adolfo J. Ariza, Robert Furberg, Lauren MacKenzie Whetstone, Connie L. Hobbs, Janet M. De Jesus, Randall H. Bender, Ilse G. Salinas, Helen J. Binns · 2013 · Contemporary Clinical Trials
77. Prolonged hyperlipidemia exposure increases the risk of arterial stiffness in young adults: a cross-sectional study in a cohort of Chinese
    Haojia Chen, Youren Chen, Weiqiang Wu, Zekai Chen, Zefeng Cai, Zhichao Chen, Xiuzhu Yan, Shouling Wu · 2020 · BMC Public Health
78. The economic impact of familial hypercholesterolemia on productivity
    Zanfina Ademi, Clara Marquina, Ella Zomer, Cate Bailey, Alice J. Owen, Jing Pang, Richard Norman, Gerald Francis Watts, Danny Liew · 2020 · Journal of clinical lipidology
79. Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis
    Yann Ilboudo, Melanie E. Garrett, Pablo Bartolucci, Carlo Brugnara, Clary B. Clish, Joel N. Hirschhorn, F. Galactéros, Allison E. Ashley‐Koch, Marilyn J. Telen, Guillaume Lettre · 2020 · Blood Cells Molecules and Diseases
80. Association between low-density lipoprotein cholesterol levels and all-cause mortality in patients with coronary artery disease: a real-world analysis using data from an international network
    Thiago Luis Scudeler, Leandro Menezes Alves da Costa, Rafael Amorim Belo Nunes, Rafael Otto Schneidewind, Thiago Midlej Brito, Daniel Castanho Genta Pereira, Roger Pereira de Oliveira, Genara Santana, Hélio José Castello, Marcelo José de Carvalho Cantarelli et al. · 2024 · Scientific Reports
81. Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
    Parth K. Shah, Charles J. Glueck, Vybhav Jetty, Naila Goldenberg, Matan Rothschild, Rashid Riaz, Gregory Duhon, Ping Wang · 2016 · Lipids in Health and Disease
82. Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis
    Montgomery Blencowe, In Sook Ahn, Zara Saleem, Helen Luk, Ingrid Cely, Ville‐Petteri Mäkinen, Yuqi Zhao, Xia Yang · 2020 · Journal of Lipid Research
83. Association between CVDs and initiation and adherence to statin treatment in patients with newly diagnosed hypercholesterolaemia: a retrospective cohort study
    In Sun Ryou, Jooyoung Chang, Joung Sik Son, Ahryoung Ko, Seulggie Choi, Kyuwoong Kim, Sung Min Kim, Sang Min Park · 2021 · BMJ Open
84. New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
    Achim Leo Burger, Edita Pogran, Marie Muthspiel, Christoph Clemens Kaufmann, Bernhard Jäger, Kurt Huber · 2022 · Biomedicines
85. Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
    Jinyoung Hong, Hyunjung Gu, Juhee Lee, Woochang Lee, Sail Chun, Ki Hoon Han, Won‐Ki Min · 2022 · Annals of Laboratory Medicine
86. Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease
    Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, Børge Grønne Nordestgaard · 2023 · Current Opinion in Lipidology
87. Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology
    Álvaro González‐Cantero, Wolf‐­Henning Boehncke, Johan DE SUTTER, José Luis Zamorano, Jo Lambert, L. Puig · 2023 · Journal of the European Academy of Dermatology and Venereology
88. Biomarkers
    Peter Libby, Kevin R. King · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
89. Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years
    Nina R. Joyce, Gregory A. Wellenius, Charles B. Eaton, Amal N. Trivedi, Justin P.V. Zachariah · 2016 · Journal of clinical lipidology
90. Statins, Ezetimibe, and Proprotein Convertase Subtilisin–Kexin Type 9 Inhibitors to Reduce Low-Density Lipoprotein Cholesterol and Cardiovascular Events
    James Henry O’Keefe, James J. DiNicolantonio, Carl J. Lavie · 2016 · The American Journal of Cardiology
91. Body fat percentage and CRP correlates with a composite score of vascular risk markers in healthy, young adults - The Lifestyle, Biomarkers, and Atherosclerosis (LBA) study
    Paul Pettersson-Pablo, Yang Cao, Torbjörn Carl Bäckström, Torbjörn Nilsson, Anita Hurtig‐Wennlöf · 2020 · BMC Cardiovascular Disorders
92. Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion
    Helena Gylling, Timo E. Strandberg, Petri T. Kovanen, Piia P. Simonen · 2020 · Nutrients
93. The Effect of T'ai Chi Exercise on Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Aqeel M. Alenazi, Mohammed M. Alshehri, Jeffrey C. Hoover, Mohammad A. Yabroudi, Shaji John Kachanathu, Wen Liu · 2017 · The Journal of Alternative and Complementary Medicine
94. Challenges in Interpreting Multivariable Mendelian Randomization: Might “Good Cholesterol” Be Good After All?
    Michael Vaclav Holmes, George Davey Smith · 2018 · American Journal of Kidney Diseases
95. Cholesterol and inflammation: The lesser the better in atherothrombosis
    Viviane Zorzanelli Rocha, Raul Dias Santos · 2018 · European Journal of Preventive Cardiology
96. MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease
    S. Urbut, M. Yeung, S. Khurshid, S. J. Cho, A. Schuermans, J. German, K. Taraszka, K. Paruchuri, A. Fahed, P. Ellinor et al. · 2024 · Nature Communications
97. Should African Americans with Hypertension Be Treated Differently than Non-African Americans?
    John M. Flack, Brian A. Ference, Phillip David Levy · 2013 · Current Hypertension Reports
98. Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective
    Enas A. Enas, Thiruvinvamalai S. Dharmarajan, Basil Varkey · 2015 · Indian Heart Journal
99. Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns
    Paul N. Hopkins, Stacey R. Lane · 2017 · Current Opinion in Lipidology
100. Lipid temporal trends in normal-weight youth
     Justin P.V. Zachariah, Teniola Shittu, Yunfei Wang · 2020 · American Heart Journal